Lawton Alison Frances 4
4 · Kaleido Biosciences, Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2019-03-04+150,000→ 150,000 totalExercise: $15.00Exp: 2029-03-04→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on January 23, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.